| 标题 |
Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TN |
| 网址 | |
| DOI |
10.1182/blood.2024024476
doi
|
| 其它 |
期刊:Blood 作者:Jeff P. Sharman; Miklós Egyed; Wojciech Jurczak; Alan P Skarbnik; Krish Patel; et al 出版日期:2025-04-08 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)